Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2025-12-26 @ 11:08 AM
NCT ID:
NCT00927212
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed Atopic Dermatitis for at least 6 months prior to enrollment.
* Diseased Body surface area (BSA) ≤ 20%.
* Male and Female ≥ 18.
* Adequate general health.
* Signed Informed consent form by the patient or his/her legal guardian.
* Patient must be able and willing to comply with all protocol requirements.
Exclusion Criteria:
* Patient who is unable to provide fully informed consent.
* Pregnant of breast-feeding females.
* Concomitant dermatologic or medical condition(s) which may interfere with the patient's response evaluation.
* Evidence of an infection in the targeted zones.
* Known sensitivity to any of the drug component.
* Immunocompromised patients.
* Concomitant medications such as:
* Topical corticosteroid within 2 weeks prior to Day 1 visit;
* Systemic steroids and immunosuppressants within 1 month prior to Day 1 visit; \*Systemic anti-histamines and antibiotics within 2 weeks prior to Day 1 visit; \*Phototherapy within 4 weeks prior to Day 1 visit;
* Anticipated exaggerated exposure to sunlight during the whole treatment period and 4 weeks prior to Day 1 visit.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00927212
Study Brief:
Protocol Section:
NCT00927212